Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 1
2015 1
2017 2
2018 1
2021 2
2022 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

9 results

Results by year

Filters applied: . Clear all
Page 1
Weakly supervised deep learning to predict recurrence in low-grade endometrial cancer from multiplexed immunofluorescence images.
Jiménez-Sánchez D, López-Janeiro Á, Villalba-Esparza M, Ariz M, Kadioglu E, Masetto I, Goubert V, Lozano MD, Melero I, Hardisson D, Ortiz-de-Solórzano C, de Andrea CE. Jiménez-Sánchez D, et al. Among authors: kadioglu e. NPJ Digit Med. 2023 Mar 23;6(1):48. doi: 10.1038/s41746-023-00795-x. NPJ Digit Med. 2023. PMID: 36959234 Free PMC article.
Overcoming microenvironmental resistance to PD-1 blockade in genetically engineered lung cancer models.
Martinez-Usatorre A, Kadioglu E, Boivin G, Cianciaruso C, Guichard A, Torchia B, Zangger N, Nassiri S, Keklikoglou I, Schmittnaegel M, Ries CH, Meylan E, De Palma M. Martinez-Usatorre A, et al. Among authors: kadioglu e. Sci Transl Med. 2021 Aug 11;13(606):eabd1616. doi: 10.1126/scitranslmed.abd1616. Sci Transl Med. 2021. PMID: 34380768 Free PMC article.
The association between the tumor immune microenvironments and clinical outcome in low-grade, early-stage endometrial cancer patients.
López-Janeiro Á, Villalba-Esparza M, Brizzi ME, Jiménez-Sánchez D, Ruz-Caracuel I, Kadioglu E, Masetto I, Goubert V, Garcia-Ros D, Melero I, Peláez-García A, Hardisson D, de Andrea CE. López-Janeiro Á, et al. Among authors: kadioglu e. J Pathol. 2022 Dec;258(4):426-436. doi: 10.1002/path.6012. Epub 2022 Oct 25. J Pathol. 2022. PMID: 36169332 Free PMC article.
Periostin Limits Tumor Response to VEGFA Inhibition.
Keklikoglou I, Kadioglu E, Bissinger S, Langlois B, Bellotti A, Orend G, Ries CH, De Palma M. Keklikoglou I, et al. Among authors: kadioglu e. Cell Rep. 2018 Mar 6;22(10):2530-2540. doi: 10.1016/j.celrep.2018.02.035. Cell Rep. 2018. PMID: 29514082 Free article.
Proteomic Analysis of Low-Grade, Early-Stage Endometrial Carcinoma Reveals New Dysregulated Pathways Associated with Cell Death and Cell Signaling.
López-Janeiro Á, Ruz-Caracuel I, Ramón-Patino JL, De Los Ríos V, Villalba Esparza M, Berjón A, Yébenes L, Hernández A, Masetto I, Kadioglu E, Goubert V, Heredia-Soto V, Barderas R, Casal JI, de Andrea CE, Redondo A, Mendiola M, Peláez-García A, Hardisson D. López-Janeiro Á, et al. Among authors: kadioglu e. Cancers (Basel). 2021 Feb 14;13(4):794. doi: 10.3390/cancers13040794. Cancers (Basel). 2021. PMID: 33672863 Free PMC article.
The Selective Tie2 Inhibitor Rebastinib Blocks Recruitment and Function of Tie2Hi Macrophages in Breast Cancer and Pancreatic Neuroendocrine Tumors.
Harney AS, Karagiannis GS, Pignatelli J, Smith BD, Kadioglu E, Wise SC, Hood MM, Kaufman MD, Leary CB, Lu WP, Al-Ani G, Chen X, Entenberg D, Oktay MH, Wang Y, Chun L, De Palma M, Jones JG, Flynn DL, Condeelis JS. Harney AS, et al. Among authors: kadioglu e. Mol Cancer Ther. 2017 Nov;16(11):2486-2501. doi: 10.1158/1535-7163.MCT-17-0241. Epub 2017 Aug 24. Mol Cancer Ther. 2017. PMID: 28838996 Free PMC article.